About the Conference

The Infectious Diseases 2025 conference invites participants from around the globe to attend the prestigious "6th Annual Meeting on Infectious Diseases, Microbiology & Beneficial Microbes," taking place June 24-25, 2025, in Paris, France. This event will feature keynote presentations, oral talks, poster sessions, and various discussions. Researchers and educators worldwide will showcase their work, highlighting ways in which men, women, and children from all backgrounds can be treated for various infectious diseases.

Infectious diseases are caused by microorganisms such as bacteria, viruses, fungi, and parasites, while microbiology is the study of these microscopic organisms. Many microbes live in and on our bodies, but under certain conditions, some can cause infections that are transmitted from person to person. Microbiology encompasses fundamental research in several fields, including cell biology, physiology, biochemistry, evolution, and clinical microbiology, focusing on how hosts respond to infections.

Emerging Infectious Diseases: Infectious diseases like Zika virus, Ebola, and COVID-19 continue to threaten global health security. Microbiology studies the factors driving the emergence of these diseases—such as ecological, environmental, and socio-economic influences—and works to develop strategies for early detection, surveillance, and rapid responses to new pathogens.

Why to Attend

Join us for the 6th Annual Meeting on Infectious Diseases, Microbiology & Beneficial Microbes, happening on June 24-25, 2025, in Paris, France. Under the theme "Innovations in Controlling Infectious Diseases, Microbiology, and Beneficial Microbes" this event offers an exciting program that includes keynote speeches, oral presentations, poster sessions, and engaging discussions. Esteemed educators and researchers from around the world will present their groundbreaking research, exploring how people from all demographics can recover from various infectious diseases. Here's why you should attend:

Cutting-Edge Research: Explore the latest innovations and breakthroughs in infectious disease control, microbiology, and beneficial microbes, presented by top experts in the field.

Networking Opportunities: Connect with fellow researchers, peers, and professionals across diverse fields, creating opportunities for collaboration and partnerships that can accelerate your research.

Multidisciplinary Perspectives: Participate in discussions that cover a broad spectrum of topics, from microbiology to public health, providing a comprehensive understanding of infectious disease management and treatment.

Practical Applications: Learn about real-world strategies and solutions that can be applied to combat infectious diseases and enhance health and well-being.

Professional Development: Expand your knowledge, skills, and professional network, positioning yourself as a leader in the fields of infectious diseases, microbiology, and beneficial microbes.

Don’t miss this chance to join a powerful gathering of experts focused on advancing the understanding and management of infectious diseases. Register now to secure your place at this transformative event.

Sessions and Tracks

Track 1: Bacterial Infections and Diseases

Bacterial infections occur when harmful bacteria invade the body, leading to various health issues. Bacteria are microscopic, single-celled organisms that can inhabit diverse environments and can be both beneficial and harmful. Pathogenic bacteria can cause illness by producing toxins, attacking cells, and triggering immune responses.

• Gram-Positive Bacteria: These have a thick cell wall. Notable examples include Staphylococcus aureus, which causes skin infections and pneumonia, and Streptococcus pyogenes, responsible for strep throat and skin infections.

• Gram-Negative Bacteria: These have a thinner cell wall. Examples include Escherichia coli, which causes UTIs and gastrointestinal infections, and Salmonella, known for causing food poisoning.

• Anaerobic Bacteria: These bacteria can survive without oxygen and are often found in deep wounds and the gastrointestinal tract. Examples include Clostridium difficile, which causes severe diarrhea, and Bacteroides fragilis, leading to intra-abdominal infections.

Common Bacterial Diseases:

• Tuberculosis (TB): Caused by Mycobacterium tuberculosis, TB primarily affects the lungs but can also impact other body parts. Symptoms include coughing, chest pain, fever, fatigue, and weight loss.

• Urinary Tract Infection (UTI): Often caused by Escherichia coli, UTIs can also be caused by other bacteria. Symptoms include frequent urination, pain during urination, cloudy or bloody urine, and pelvic pain.

• Salmonellosis: Caused by various strains of Salmonella, salmonellosis is typically contracted from contaminated food or water, with symptoms including diarrhea, fever, abdominal cramps, nausea, and vomiting.

Track 2: Viral Infections and Diseases

Viral infections are caused by viruses, tiny infectious agents that replicate inside living cells. Viruses can infect humans, animals, plants, and bacteria.

• Influenza (Flu): A highly contagious respiratory infection with symptoms including fever, cough, sore throat, muscle aches, and fatigue.

• Ebola Virus Disease: A severe, often fatal illness with symptoms such as fever, headache, muscle pain, fatigue, diarrhea, vomiting, and bleeding.

• Zika Virus Infection: Spread by Aedes mosquitoes, causing mild symptoms like fever, rash, and joint pain, with potential birth defects if contracted during pregnancy.

• Herpes: Caused by HSV-1 and HSV-2, leading to painful sores, itching, and flu-like symptoms.

Track 3: Fungal Infections

• Fungal infections are caused by fungi, microorganisms that can lead to a variety of diseases affecting different parts of the body. Fungi are widespread in the environment and can invade the body, causing health issues.

• Athlete's Foot (Tinea Pedis): This common fungal infection primarily affects the feet, causing itching, burning, redness, and peeling of the skin, especially between the toes.

• Ringworm (Tinea Corporis): Ringworm is a fungal infection that can appear anywhere on the body. It is characterized by a red, ring-shaped rash with clear skin in the center, which may be itchy or painful.

• Yeast Infections: Caused by an overgrowth of Candida fungi, including Candida albicans, yeast infections can affect the mouth (oral thrush), genitals (vaginal yeast infection), and skin folds. Symptoms typically include itching, redness, swelling, and white discharge.

Track 4: Parasitic Infections

Parasitic infections are caused by parasites, organisms that live on or inside a host and rely on it for nourishment and survival. These parasites can include protozoa, helminths (worms), or ectoparasites like ticks and lice. Infections can occur through contaminated food or water, insect bites, or contact with contaminated soil. Common parasitic infections include:

• Malaria: Caused by the Plasmodium parasite and transmitted by infected female Anopheles mosquitoes. Symptoms include fever, chills, and flu-like symptoms, which can be life-threatening without prompt treatment.

• Toxoplasmosis: Caused by the Toxoplasma gondii parasite, commonly found in cat feces. It can be contracted through contaminated food or water and may cause flu-like symptoms or severe complications, especially in pregnant women and immunocompromised individuals.

• Tapeworm Infections: Result from various species of tapeworms, often through undercooked or contaminated meat. Symptoms can include abdominal pain, weight loss, and nutritional deficiencies.

Treatment usually involves specific medications for the parasite, while prevention includes good hygiene practices, proper food handling, avoiding contaminated water, and using insect repellent.

Track 5: Prion Diseases

Prion diseases, or transmissible spongiform encephalopathies (TSEs), are rare, progressive neurodegenerative disorders caused by abnormal prion proteins. Unlike other pathogens, prions lack DNA or RNA.

• Creutzfeldt-Jakob Disease (CJD): The most common prion disease in humans, presenting in sporadic, familial, or acquired forms. Symptoms include rapid dementia, muscle stiffness, involuntary movements, and eventually coma and death.

• Variant Creutzfeldt-Jakob Disease (vCJD): Associated with consuming prion-contaminated beef, particularly from bovine spongiform encephalopathy (BSE), or "mad cow disease." It has a younger onset age and may present with psychiatric symptoms.

• Gerstmann-Sträussler-Scheinker Syndrome (GSS): A rare inherited prion disease causing ataxia, dementia, and other neurological symptoms, linked to mutations in the prion protein gene (PRNP).

• Fatal Familial Insomnia (FFI): An inherited prion disease marked by progressive insomnia, autonomic dysfunction, and dementia, also caused by mutations in the PRNP gene.

Currently, prion diseases have no cure and are invariably fatal. Treatment focuses on symptom management and supportive care. Prevention includes avoiding contaminated meat and implementing stringent infection control in healthcare settings.

Track 6: Probiotics and Prebiotics

Probiotics and prebiotics both support gut health but function differently. Probiotics are live microorganisms, typically bacteria or yeast, that confer health benefits when consumed in adequate amounts. These beneficial microbes are similar to those naturally found in the gut and are present in foods like yogurt, kefir, sauerkraut, kimchi, and in supplement form. They help maintain a healthy gut flora by encouraging the growth of beneficial bacteria and suppressing harmful ones. Probiotics have been linked to improved digestion, enhanced immune function, relief from irritable bowel syndrome (IBS), and even mental health support.

Prebiotics, on the other hand, are types of fiber that nourish beneficial gut bacteria. They are not digested by the human body but pass through to the colon, where they are fermented by gut bacteria, producing short-chain fatty acids that fuel colon cells and support gut health. Found in foods like bananas, onions, garlic, leeks, asparagus, chicory root, and whole grains, prebiotics work synergistically with probiotics to promote overall well-being.

Track 7: Biofertilizers

Biofertilizers are substances containing living microorganisms that enhance plant growth by improving the availability of essential nutrients. They offer an eco-friendly alternative to chemical fertilizers by utilizing natural processes such as nitrogen fixation, phosphorus solubilization, and potassium mobilization.

• Nitrogen-Fixing Biofertilizers: These include bacteria like Rhizobium, Azotobacter, Azospirillum, and cyanobacteria, which convert atmospheric nitrogen into ammonia usable by plants. They are especially beneficial for leguminous crops such as soybeans, peas, and beans.

• Phosphorus-Solubilizing Biofertilizers: Containing microorganisms like Bacillus and Pseudomonas bacteria, and fungi such as Aspergillus and Penicillium, these biofertilizers solubilize insoluble phosphorus in the soil, making it available to plants. Phosphorus is crucial for plant growth and development.

• Potassium-Mobilizing Biofertilizers: These include microorganisms like Bacillus mucilaginosus and fungi like Aspergillus niger, which help mobilize potassium in the soil, enhancing its accessibility to plants.

Track 8: Gene Expression

Gene expression is the process by which information from a gene is used to synthesize a functional gene product, typically proteins or RNA molecules. It involves several key steps:

• Transcription: In the nucleus, DNA unwinds, and RNA polymerase binds to the promoter region of a gene to synthesize messenger RNA (mRNA). This mRNA carries genetic information from the DNA to the cytoplasm.

• RNA Processing (in Eukaryotes): Pre-mRNA undergoes modifications including capping (adding a 5' cap), splicing (removing introns), and polyadenylation (adding a poly-A tail). These changes stabilize the mRNA and prepare it for translation.

• Translation: In the cytoplasm, ribosomes read the mRNA sequence and translate it into a polypeptide chain. Transfer RNA (tRNA) molecules bring amino acids to the ribosome, where they are assembled into proteins based on the mRNA sequence.

Gene expression is tightly regulated by environmental signals, developmental cues, and cellular pathways, ensuring genes are expressed correctly. Dysregulation can lead to diseases such as cancer and genetic disorders.

Track 9: Mutations

Mutations are changes in the DNA sequence of an organism's genome and can have varying effects. While some mutations may be harmless or even beneficial, particularly when they contribute to genetic diversity and adaptation, others can disrupt essential cellular functions or regulatory mechanisms. Such detrimental mutations may lead to genetic disorders or increase the risk of diseases like cancer. For example, mutations causing cystic fibrosis, sickle cell disease, or Huntington's disease can result in severe health conditions. Additionally, as cells divide, mutations can accumulate, particularly in rapidly dividing cells like those in the skin or gastrointestinal tract. This accumulation can disrupt normal cell growth and division, potentially leading to cancer. Despite their potential negative effects, mutations are a natural part of biological processes and crucial for evolution. Ongoing research aims to understand their roles in health and disease, and to develop strategies for managing or treating genetic disorders.

Track 10: Sexually Transmitted Diseases (STDs) and Infections (STIs)

Sexually transmitted diseases (STDs) and infections (STIs) are infections commonly spread through sexual activities, including vaginal, anal, or oral sex. They can be caused by bacteria, viruses, parasites, or fungi. Common STDs/STIs include:

• Chlamydia: Caused by Chlamydia trachomatis, it can infect the genital tract and cause symptoms like discharge, painful urination, and pelvic pain. Untreated, it may lead to pelvic inflammatory disease (PID) and infertility.

• Gonorrhea: Caused by Neisseria gonorrhoeae, it can infect the genital tract, rectum, and throat, potentially causing discharge, painful urination, or no symptoms at all. It can also lead to PID and infertility if untreated.

• Syphilis: Caused by Treponema pallidum, it progresses through stages with symptoms ranging from painless sores (chancre) to rash, fever, and potentially severe neurological complications if untreated.

• Human Papillomavirus (HPV): A group of viruses that can cause genital warts and various cancers, including cervical, anal, and throat cancer. Many people are asymptomatic but can still transmit the virus.

• Herpes Simplex Virus (HSV): Types 1 and 2 cause genital herpes, characterized by painful sores or blisters. The virus can be transmitted even without visible symptoms.

• HIV/AIDS: Human Immunodeficiency Virus (HIV) weakens the immune system, leading to Acquired Immunodeficiency Syndrome (AIDS), the most severe stage of HIV infection.

Prevention includes consistent and correct use of condoms, limiting sexual partners, and regular STD testing. Early detection and treatment are crucial for managing STDs and reducing transmission risk.

Track 11: COVID-19

COVID-19, or Coronavirus Disease 2019, is an infectious illness caused by the novel coronavirus SARS-CoV-2. First identified in Wuhan, China, in December 2019, it rapidly spread globally, leading to a pandemic declared by the World Health Organization (WHO) in March 2020. The virus primarily spreads through respiratory droplets from coughs, sneezes, or talks, and can also spread by touching contaminated surfaces and then touching the face. Symptoms range from mild to severe, including fever, cough, shortness of breath, fatigue, and loss of taste or smell. Severe cases can lead to pneumonia, acute respiratory distress syndrome (ARDS), and death, particularly among older adults and those with underlying health conditions. Public health measures to curb the spread include wearing masks, physical distancing, frequent handwashing, and vaccination campaigns. The pandemic has profoundly impacted global health systems, economies, and daily life, prompting ongoing efforts to manage and mitigate its effects.

Track 12: Antigen-Antibody Reactions

Antigen-antibody reactions are vital to the immune system's defense mechanisms. An antigen is any substance that triggers an immune response, including foreign pathogens like bacteria and viruses, or non-infectious substances such as pollen. Antigens are typically large molecules recognized as foreign by the immune system. An antibody, or immunoglobulin, is a protein produced by B cells in response to an antigen. Each antibody has a unique binding site that specifically recognizes and binds to its corresponding antigen. These interactions are crucial for immunity against diseases, allergic responses, autoimmune disorders, and diagnostic tests like immunoassays. Understanding antigen-antibody reactions is essential for developing effective vaccines, therapeutics, and diagnostic tools, as they play a central role in detecting and combating infections and diseases.

Track 13: Advancements in Vaccines and Therapeutics

Recent advancements in vaccines and therapeutics have revolutionized disease prevention and treatment. mRNA vaccines, such as those developed by Pfizer-BioNTech and Moderna for COVID-19, use genetic material to prompt cells to produce proteins that elicit an immune response. These vaccines offer advantages like rapid development and broad applicability. Vector-based vaccines, such as those by Oxford-AstraZeneca and Johnson & Johnson, use harmless viruses to deliver pathogen genes into cells, stimulating an immune response. Thermostable vaccines, which remain effective at higher temperatures, are being developed for diseases like COVID-19 and malaria to improve distribution. Therapeutic advancements include monoclonal antibodies, which target specific proteins on pathogens or diseased cells, and antiviral drugs that inhibit viral replication. These innovations improve treatment efficacy and accessibility, advancing our ability to combat various diseases and conditions.

Track 14: Infectious Diseases and Cancer

Infectious diseases are caused by pathogens such as bacteria, viruses, parasites, or fungi and can spread through various routes, including direct contact, contaminated surfaces, and vectors. Examples include bacterial infections like tuberculosis and syphilis, viral infections such as influenza and HIV/AIDS, parasitic infections like malaria, and fungal infections such as candidiasis. Prevention strategies include vaccination, proper hygiene, and vector control. Cancer, on the other hand, is characterized by uncontrolled cell growth and spread, forming tumors that disrupt normal body functions. It can be caused by genetic factors, environmental exposures, lifestyle choices, and infections. Common cancers include breast, lung, and colorectal cancer. Treatments vary and may include surgery, chemotherapy, radiation therapy, and immunotherapy. Prevention focuses on lifestyle changes and early detection through screening. Ongoing research aims to improve understanding, prevention, and treatment of both infectious diseases and cancer.

Track 15: Veterinary Infectious Diseases

Veterinary infectious diseases affect animals such as pets, livestock, and wildlife, and can sometimes impact humans. These diseases, caused by bacteria, viruses, parasites, or fungi, significantly affect animal health, welfare, and productivity. Examples include:

• Canine Distemper: A viral disease in dogs causing respiratory, gastrointestinal, and neurological symptoms. It can be fatal, especially in puppies and unvaccinated dogs.

• Feline Panleukopenia: Also known as feline distemper, this viral infection in cats leads to fever, vomiting, diarrhea, and decreased white blood cells. It is highly contagious and often fatal in kittens.

• Rabies: A viral disease affecting mammals, including dogs and cats. Transmitted through bites, it impacts the central nervous system, leading to neurological symptoms and death. It is zoonotic and can be transmitted to humans.

• Foot-and-Mouth Disease (FMD): A contagious viral disease in cloven-hoofed animals, causing fever and blisters. It results in economic losses due to trade restrictions.

Control measures include vaccination, biosecurity, vector control, and quarantine, with veterinarians playing a key role in disease management and public health protection.

Abstract Submission criteria & eligibility

Presentation Requirements

Presenting authors are responsible for their own registration, travel, and hotel expenses. Accepted abstracts will receive an acceptance email, which will allow authors to register for the conference. Abstracts will be compiled and included in the conference book, which will be available to participants. If a presenter is unable to attend, they must arrange for a qualified substitute to present their paper or poster. Please inform the conference team if such a change is necessary.

Submission Options

• Oral Paper Presentations: 30-minute time slots, organized into theme-based sessions.
• Keynote Session: 45-minute time slot.
• Workshop/Special Session and Symposium: 60-minute time slots, with an additional 5-minute Q&A session for the symposium.

Graduate and Master's students can submit abstracts for poster and e-poster presentations. PhD students can submit abstracts for the Young Researcher’s Forum (YRF), poster, and e-poster presentations. The YRF category includes short oral presentations specifically for PhD students.

Extended Abstracts: Should use the Abstract Template provided. This category accepts original empirical research, theoretical development, reviews, or critiques.

Participation / presentation option

Oral Presentation: Oral presentations can cover a range of topics, including research findings, theoretical developments, professional practices, or personal experiences that provide valuable insights for others. Presenters should prepare to speak for 20-25 minutes if assigned a 30-minute slot, leaving the remaining time for questions and discussion. Keynote speakers are allotted 45 minutes, with 40-45 minutes for their talk and the remainder reserved for audience interaction, facilitated by the Session Chair.

Workshop: Workshops will delve deeper into specialized techniques and detailed demonstrations on topics similar to those of oral presentations. Typically lasting 45-50 minutes, workshops provide a platform for presenters to offer more comprehensive insights and hands-on experiences. Teams interested in conducting workshops can collaborate with research coordinators and benefit from special group registration waivers.

Poster Presentation: The Student Poster Competition at Infectious Diseases 2025 is aimed at encouraging students and recent graduates to showcase their original research. Presenters will have 5-7 minutes to discuss their posters, followed by a Q&A session with judges who may ask questions during the evaluation. This competition offers young scientists a chance to engage with peers’ recent findings and enhance their multidisciplinary research skills. Posters will be displayed in hard copy format, measuring 1x1 meter.

Webinar: For those unable to attend in person due to scheduling conflicts or other reasons, webinars offer an alternative. Presenters can record their presentations, which will be featured in a dedicated webinar session, allowing remote attendees to view the content.

E-Poster: Similar to webinars, e-Posters are presented digitally. They will be published on the conference website, with abstracts appearing in the conference souvenir and journal, complete with a DOI.

Exhibition: Infectious Diseases 2025 provides opportunities for commercial and non-commercial organizations—such as drug manufacturers, clinical trial sites, management consultants, chemists, pharmacists, and equipment manufacturers—to exhibit their products and services. For details on exhibitor booths and benefits, visit "WHY TO EXHIBIT WITH US?"

Advertisement: The conference program is a key resource for attendees, frequently referenced throughout the event. Advertising in the conference program offers excellent marketing opportunities and can help establish long-term business relationships.

For further information or queries, please contact asianmicrobiology@europeconferences.com